Back to News
No items found.
No items found.
VitalTrace receives $4M from the WA government to establish a new manufacturing facility
VitalTrace is proud to announce it has received support from the Cook government, under the Investment Attraction Fund (IAF) which supports WA advanced manufacturing projects as part of an effort to diversify the Western Australia economy.
August 1, 2023
•
3 min read
VitalTrace is proud to announce it has received support from the Cook government, under the Investment Attraction Fund (IAF) which supports WA advanced manufacturing projects as part of an effort to diversify the Western Australia economy.
The IAF is intended to enable new investment into a range of industries, facilitating a more targeted and coordinated approach to investment attraction supporting the WA Government's economic diversification framework, Diversify WA.
Roger Cook, Premier of Western Australia said “Backing local companies to manufacture here in WA, to value-add, and to take on the world in developing high-tech products for the future.”
The dedicated and growing team at VitalTrace hopes to make good on Premier Cook’s support and create a nation first continuous lactate biosensor manufacturing facility.
No items found.
VitalTrace awarded $656,666 for the Clinical translation of a novel continuous lactate biosensor for fetal monitoring
VitalTrace was founded to improve the safety for mothers and babies during childbirth - babies being some of our youngest and most vulnerable patients.
September 30, 2023
•
3 min read
VitalTrace was founded to improve the safety for mothers and babies during childbirth - babies being some of our youngest and most vulnerable patients. We are passionate about eliminating the unnecessary health, psychological and economic burdens from inaccurate childbirth monitoring.
This project will progress development and clinical testing of a continuous lactate sensor, with the potential to revolutionise fetal monitoring during labour globally.
Current fetal monitoring technology is inaccurate, subjective and creates difficulties for clinicians leading to complications for mothers and babies. VitalTrace is developing DelivAssureTM, a breakthrough technology designed to continuously monitor clinically validated biomarkers to reduce fetal morbidities and wirelessly transmit readings to an associated display monitor.
The funding awarded through the Clinical Translation and Commercialisation Medtech grant, will help design and run VitalTrace's first clinical trial, testing DelivAssureTM, a novel continuous lactate biosensor, which has already received Breakthrough Device designation from the US FDA.
No items found.
VitalTrace awarded $500,000 by the Future Health Research and Innovation (FHRI) Fund
VitalTrace is proud to announce it is one of 9 WA innovators and start ups to have received support from the Western Australian government, under the Future Health Research and Innovation (FHRI) Fund.
October 1, 2023
•
3 min read
VitalTrace is proud to announce it is one of 9 WA innovators and start ups to have received support from the Western Australian government, under the Future Health Research and Innovation (FHRI) Fund.
The Innovation Seed Fund is intended to bridge the gap in access to early-stage funding for WA start-ups to be more competitive in securing follow-on funding and develop into sustainable businesses, create high-level health sector jobs and enhance the production/manufacturing capacity of WA.
This project will fund the development of a commercialisation ready and clinically compatible product to improve maternal and fetal health outcomes during childbirth.
Medical Research Minister Stephen Dawson said “[VitalTrace has] the potential to change lives, and this funding will help them secure capital and develop into sustainable businesses.”